BACKGROUND 77
Malaria remains a major global health problem, with approximately one billion people living at 78 high-risk of being infected [1] . Plasmodium spp. infection impacts the health of the poorest and 79 marginalized communities in the endemic countries, particularly in infants and pregnant women, 80 with around 125 million pregnancies at risk of infection each year [2] . Malaria during pregnancy, 81 especially falciparum-malaria, can be devastating and fulminant, leading to high mortality for both 82 mother and fetus [3] . During pregnancy, the infected erythrocytes accumulate and sequester in the 83 placental intervillous space, causing placental histopathological changes, which triggers an 84 exacerbated inflammatory response that is highly detrimental [4] . The deleterious effects caused by 85 malaria infection during pregnancy depend on various factors, such as the woman's immunity, the 86 number of previous pregnancies and the trimester of gestation, with primigravida and 87 secundigravida women most susceptible and suffering the greatest consequences [5] . 88
A heightened inflammatory response perturbs the maternal-fetal interface and impairs critical 89 placental functions. Therefore, maternal malaria presents a major impact on fetus and newborns, 90 being the main cause of abortion, stillbirth, premature delivery and fetal death in malaria-endemic 91 countries [3] . Low birth weight (LBW) caused by prematurity or intrauterine growth retardation 92 (IUGR) is commonly observed in babies born from mothers who had malaria during pregnancy, 93 contributing to around 100,000 infant deaths each year [3, 5, 6] . Additionally, in utero exposure to 94 malaria parasites has been shown to impact the fetus or newborn head circumference (HC), a 95 proportional reduction as an outcome of the IUGR [7, 8] . Albeit, no further studies have tried to 96 unpick a specific disproportionate HC reduction associated with malaria during pregnancy. 97
Several studies have reported the association of intrauterine infections with a high risk of the 98 newborn to have LBW and brain injury [9] . A group of microorganisms designated as TORCH, an 99 abbreviation for Toxoplasma, rubella, cytomegalovirus, and Herpes simplex that now also comprise 100 T. pallidum (Syphilis), hepatitis virus, and HIV, and recently, the Zika virus are frequently 101 associated with reduced HC in newborns [10, 11] . The more adverse consequence that results from 102 8 during pregnancy. At the time of delivery, clinical data were collected from mother and newborn, as 137 well as a placental biopsy and blood samples. 138
 Samples processing 139
The peripheral and placental blood was collected in heparin tubes and then separated into plasma 140 and whole blood cells using a centrifuge. Thin and thick blood smears were stained with Giemsa. 141
The placental biopsies were fixed in 10% neutral buffered formalin at 4°C until they could be sent 142 to the University of São Paulo for processing. Paraffin-embedded 5µm sections of placental tissue 143
were stained with Hematoxylin-Eosin (H&E) or Giemsa for histological examination. Total DNA 144 was obtained from whole blood cells using a commercially available extraction kit (QIAmp DNA 145
Mini Kit, Qiagen), following the manufacturer's instructions. 146
 Gestational age estimation 147
The gestational age of all women from the PCS was estimated by woman's last menstrual period 148 (LMP) and adjusted by ultrasound during the first trimester of pregnancy. 149
 Newborns classification according to head circumference 150
Based on the gestational age, and on the HC size and gender, each newborn from the PCS was 151 assigned into groups using the INTERGROWTH-21 st Project [16] . An individual was in a normal 152 head circumference (NHC) range if their HC was within one SD of the median. Newborns with HC 153 below one SD below the median were considered to have a small head (SH) [17] . Newborns with 154 HC below two SD below the median were classified as having microcephaly (MC) [ The angiogenic factors, vascular endothelial growth factor A (VEGFA, and it receptors 179 VEGFR1/FLT1 and VEGFR2/FLK1), angiopoietins 1 and 2 (ANG-1 and ANG-2, and their 180 associated soluble receptor the TEK receptor tyrosine kinase (TIE-2)), and the leptin hormone were 181 measured in placental plasma (1:20 dilution for all factors) using the DuoSet ELISA development 182 kits (R&D), according to manufacturer's guidelines. 183
 Screening of other infectious agents 184
All pregnant women were screened in the local ANC clinics for toxoplasmosis, hepatitis, syphilis, 185 and HIV by measuring antibodies titers, following the Brazilian MoH guidelines. Further, 186
peripheral plasma from women that delivered babies with small head and microcephaly, 187
irrespective of the infection status and Plasmodium species, was tested to confirm the absence of 188 other infectious agents during pregnancy. Tests for Toxoplasma gondii, Rubella, Cytomegalovirus, 189
Herpes simplex virus, Syphilis, HIV, Dengue virus, Chikungunya virus, and Zika virus were 190 performed retrospectively by ELISA assays in peripheral blood collected until the 28 weeks of 191 gestation. In pregnant women that delivered babies with microcephaly, plasma samples of two in the medical records of the mother and the newborn. This was followed by the collection and 231 collation of the data to evaluate the newborns further. 232
 Gestational age estimation 233
The gestational age in the RCS was established mainly by the woman's last menstrual period 234 (LMP). These data were obtained from the medical records. The LMP method is recommended by 235 the Brazilian MoH for gestational age calculation when it is not possible to use ultrasound. 236
 Newborns classification according to head circumference 237
Based on the gestational age estimation methodologies, and on the HC size and gender, each 238 newborn from RCS was assigned into groups using the WHO child growth standards (WHO-CGS) 239
[25]. Gestational age assessment is considered accurate when acquired through ultrasound 240 performed early in the first trimester, but the date of the last menstrual period is considered 241 unreliable [26]. According to WHO guidelines, the WHO-CGS provides an appropriate reference 242 standard for term neonates when gestational age is not reliably known. An individual was in a 243 normal head circumference (NHC) range if their HC was within one SD of the median, ( 
Newborn anthropometric measures 260
In the two cohort studies, PCS and RCS, the newborn anthropometric measures were obtained 261 immediately after the delivery, maximum within 24h, by trained nurses. Weight was measured in 262 grams (g) using digital pediatric scales, with a precision of 5 g, and the length and occipitofrontal 263 head circumference (HC) were measured in centimeters (cm), using a non-stretching flexible 264 measuring tape. Rohrer's ponderal index is the newborns' weight in grams divided by the cube of 265 the length in centimeters, and babies are considered proportional when values are above 2.5, 266 13 corresponding to the 10 th percentile [27] . An Apgar score indicates the physical condition of the 267 newborn, relative to its response to stimulation, skin coloration, heart rate, respiratory effort, and 268 muscle tone. If the Apgar Score is between 7 and 10 the newborn is considered normal; if it is 269 between 4 and 6 it is indicative that some assistance for breathing might be required; and below 4, 270 the baby needs several interventions [28] . 271 272
Exclusion criteria 273
Our analysis was restricted to babies that had been born at term (37 -42 weeks of gestation) with at 274 least 2500 grams of weight in a single birth and from mothers of fertile age (13 -47 years old). 275
Women were excluded if they had a history during pregnancy of smoking, drug use and/or alcohol software. Continuous variables were summarized using means and SD, medians, and interquartile 285 ranges (IQR). Categorical variables were summarized using frequencies and percentages. 286
Differences between groups were evaluated using Mann-Whitney U-tests accordingly. Categorical 287 data and proportions were analyzed using chi-square tests. All p-Values were 2-sided, at a 288 significance level of 0.05. To assess the association between malaria and microcephaly, adjusted 289 odds ratios (OR) with 95% confidence intervals (CI) were estimated using a multivariate logistic 290 regression approach. These models included infection by malaria (no/yes), maternal age (≥ 18 years 291 old / ≤ 17 years old) and the number of gestations (two or more/one) as explanatory variables and 292 14 SH (yes/no) or microcephaly (yes/no) as response variables. The first category for each explanatory 293 variable was considered as reference [29] . Missing data were imputed or "filled in" within a 294 multiple imputation framework using the "MICE" library within the R software [30, 31] . In 295 particular, 5 datasets were completed and the results pooled across allowing for the uncertainty in 296 the imputation process. 297
The current sample sizes present a deviation from those proposed at the outset. It was proposed to 298 enroll ~400 infected and ~800 non-infected pregnant women into the prospective cohort study. We 299 were unable to recruit to this 2:1 ratio, as some initially included in the non-infected group, were 300 transferred to an infected group upon Plasmodium molecular detection. 301
The manuscript was written according to the STROBE statement guidelines. 302 303 15
RESULTS 304

Study Population 305
A total of 600 pregnant women were enrolled in a prospective cohort study (PCS) and followed 306 until delivery. Of the first eligible maternal-child pairs, 409 (68.2%) met the inclusion criteria ( Fig.  307 2). Among the 409 newborns, 251 were born from mothers that had malaria infection during 308 pregnancy, P. vivax (Pv), P. falciparum (Pf) or both (mixed) (Fig. 2) . Overall, there were no 309 relevant maternal and newborns baseline differences between the distinct groups (Supplementary 310
Tables S1 and S2). Nonetheless, women that were Plasmodium-infected presented few 311 characteristics at delivery that were slightly different from the Non-Infected group: less weight gain, 312 lower hematocrit, lower hemoglobin, and reduced placental weight (Supplementary Tables S1). 313
314
Reduced head circumference in newborns from women infected with P. falciparum during 315 pregnancy 316
The frequency distribution of the newborns HC born from non-(NI) and malaria-infected mothers 317 (Malaria), including LBW and preterm babies, evidenced differences between the two groups. The 318 Malaria group displayed a deviated peak and spread to the left when compared with the NI group, 319
indicative of more newborns with reduced HC (p = 0.005) ( Fig. 3a) . Nevertheless, to assure that the 320 observed difference was not due to the LBW and preterm babies, these newborns were removed 321 from the analysis and segregated the malaria-infected group into Plasmodium species infected 322 groups. Even though, it was possible to observe an apparent deviation of the peak of the P. 323 falciparum-infected group (Pf) from the non-infected (NI) (p = 0.023) (Fig. 3b) , indicating a higher 324 frequency of babies with smaller HC when mothers are infected by P. falciparum. 325
Among the evaluated newborns in the PCS, 70 (17.1%) babies presented with a small head (SH), 326 including 15 (3.7%) with microcephaly ( Fig. 3c ). The evaluated babies were considered 327 proportionate through the Rohrer Index, independently of the HC size ( Supplementary Table S3 ). 328
Further, to evaluate the association of malaria during pregnancy with fetus head growth, the 329 16 newborns were segregated by HC and the mother infection status: non-infected, P. vivax-, mixed-or 330 P. falciparum-infected. The prevalence of newborns with SH was higher among babies born from 331 women infected with P. falciparum (30.7%) during pregnancy. Similarly, the prevalence of 332 microcephaly doubled when a P. falciparum infection has occurred (8.1%) (Fig. 3c) . In fact, a 333 multivariate logistic regression analysis identified P. falciparum infection as increasing the odds of 334 occurring SH in newborns (OR 3.15, 95% CI 1.52-6.53, p = 0.002) (Fig. 3c ). Likewise, it revealed a 335 higher likelihood of occurring microcephaly in babies born from mothers that were P. falciparum-336 infected (OR 5.09, 95% CI 1.12-23.17, p = 0.035) (Fig. 3c ). Strikingly, P. vivax infection during 337 pregnancy was not found to be associated with reduced HC (for SH, OR 1.30, 95% CI 0.66-2.59, p 338 = 0.449). Maternal-child pairs that presented misleading factors such as TORCH infections, 339
Syphilis, HIV, Dengue, Chikungunya, and Zika virus, and alcoholism and drug use declared in the 340 medical records, or identified in all mothers that delivered babies with were discarded SH 341
( Supplementary Tables S4 and S5) . falciparum infection (54% and 72%, respectively), as opposed to 48% in placentas from newborns 350 with NHC (Pf-NHC) ( Table 1) . 351
The analysis of placental histology parameters and angiogenic factors disclosed substantial 352 differences between non-infected controls and P. falciparum-infected groups. Of note, in all P. (Fig. 4c, d) . On the other hand, the syncytial nuclear aggregates (SNA) and (Fig. 4g, h) , as well, 360
when Pf-SH was compared to Pf-NHC. Moreover, the Leptin levels were markedly reduced in the 361
Pf-SH and Pf-MC groups (19.5 [4.5-37.2], p = 0.013 and 16.7 [9.0-26.7], p = 0.027, respectively) 362 when compared to the Non-Infected (33.1 [17.2-47.4]) ( Fig. 5i) . Complete data details can be found 363
in Supplementary Table S6 . and, 4.5 [3.2-6.6], respectively) ( Supplementary Table S7 ). These results support a placental 369 dysfunction upon P. falciparum infection, which in some parameters are specifically heightened in 370 placentas derived from babies with reduced HC, like the syncytial nuclear aggregates. 371 372 Retrospective cohort study corroborates the reduced head circumference association with P. 373
falciparum infection 374
Further, a population-based retrospective cohort study (RCS) was conducted to confirm the 375 association results. A total of 4697 maternal-child pairs were included, and upon application of the 376 exclusion criteria, 3882 (83%) newborns remained to be evaluated, of which, 232 were born from 377 mothers that had malaria infection during pregnancy (Fig. 2) . Overall, there were no significant 378 differences in baseline characteristics between the PCS and the RCS (Supplementary Tables S1, S2, 379 and S8). The evaluation of the frequency distribution of the newborns HC born from non-(NI) and 380 malaria-infected mothers (Malaria), showed differences between the two groups (p = 0.008) (Fig.  381  6a) . Identical to the PCS, when the LBW and preterm babies were removed from the analysis, and 382 the malaria-infected group segregated, the P. falciparum-infected group (Pf) presented a deviated 383 peak from the non-infected (NI) (p = 0.015) (Fig. 6b ). Indicative of a higher frequency of newborns 384 with reduced HC when mothers are infected with P. falciparum during pregnancy. 385
The evaluated newborns included 934 (24.1%) babies with SH and 161 (4.2%) with microcephaly. 386
In the RCS, similarly to the PCS, the prevalence of newborns with SH was more than one-half 387 higher (36.6%) among babies born from P. falciparum-infected mothers, and the microcephaly 388 prevalence almost doubled in the presence of a P. falciparum infection (7.3%) (Fig. 6c) . 389
Analogously, the multivariate logistic regression analysis revealed that P. falciparum infection 390 increases the odds of occurring SH in newborns (Odds ratio [OR] 1.91, 95% CI 1.21-3.04, p = 391 0.006) ( Fig. 6c ). Altogether, these results demonstrate that P. falciparum infection during 392 pregnancy increases the likelihood of occurring reduced HC in the newborns, corroborating the 393 results obtained in the PCS. 394
19
DISCUSSION 395
It is well-established that malaria during pregnancy increases the risk of adverse fetal outcomes, 396 such as abortion, IUGR, premature births and LBW. We show for the first-time evidence that P. 397 falciparum infection during pregnancy is significantly associated with the occurrence of reduced 398 HC in the newborns, and to some extent, with microcephaly. The revealed newborn HC reduction is 399 independent of the already known impact that malaria has on the whole fetal growth, as LBW and 400 preterm newborns were deliberately excluded from our analysis. 401
The increased risk for developing reduced HC associated with P. falciparum infection was 402 supported by a prospective study (PCS) (Odds Ratio (OR) 3.15, p = 0.002) and subsequently 403 corroborated by a retrospective study (RCS) (OR 1.91, p = 0.006). Remarkably, in the prospective 404 study, the OR doubles when we consider only the microcephaly cases (OR 5.09, p = 0.035). These 405 observations reinforce the knowledge that malaria during pregnancy increases the risk of problems 406 in fetal development [3] [4] [5] . 407
We hypothesize that the placental inflammatory process acting upon P. falciparum infection is 408 contributing to impair the fetal head growth. This hypothesis is supported by the observation of 409 histopathological alterations, combined with an imbalance in angiogenic factors production and 410 inflammatory factors in placentas from babies with congenital SH or microcephaly when mothers 411 were P. falciparum-infected. A local inflammation can generate a frame of hypoxia/ischemia that 412 would alter the transportation of both nutrients and respiratory gases to the unborn baby, which can 413 impact on cranial malformation due to the lack of an adequate supply of nutrients and oxygen [33] . 414 Also, the oxidative stress caused by hypoxia leads to several structural and functional alterations in 415 the intrauterine development [34]. This scenario is often observed in cases of placental malfunction 416 due to different etiologies, and prolonged and premature labor [35] . 417
Interestingly, the values of SNA or syncytial knotting, which has been associated with IUGR due to 418 local hypoxia/oxidative stress [32] , were highly increased in placentas from the Pf-SH and Pf-MC 419 groups when compared to the other control groups. Syncytial knotting has repeatedly been observed 420 20 in placentas from P. falciparum-exposed women [4, 19, 36] . In fact, the major placental alterations 421 observed, including syncytial knots and monocytes inflammatory infiltrate, are consistent with 422 previous reports on placental inflammatory responses due to sequestration of P. falciparum 423 parasites in the placenta, which characterizes the placental malaria development [4, 5, 19] . The 424 evaluation of cytokine levels and complement in our samples did not show an overall alteration. 425
Nevertheless, these only reflect a picture at the moment of birth. It is unsurprising that P. vivax 426 infection was not associated with the head reduction phenotype, as this parasite is known as not 427 sequestering in the placenta. Previous studies have demonstrated that P. vivax infection during 428 pregnancy induces a less placental inflammatory process when compared with P. falciparum 429
The presence of residual tissue lesions and impaired leptin production constitute clear evidence of 431 damage. In fact, the Pf-SH and Pf-MC groups presented deregulated leptin levels. The impaired 432 production of leptin, a hormone commonly produced in substantial amounts by the placenta, can be 433 related to placental inflammation upon infection. Also, leptin has been shown associated with fetal 434 growth restriction [37] . Regarding the Pf-SH group, few observed differences reached statistical 435 significance, possibly due to the small sample size of this group, but the overall placental malaria 436 phenotype is more prominent and widespread than in non-infected and Pf-NHC groups. 437
Nevertheless, it is unclear how placental alterations due to inflammation impact on the development 438 of the fetus. 439
Currently, much of what is known about falciparum gestational malaria is based on studies 440 performed in African high transmission areas, which in general are settings that have precarious 441 health systems and inadequate or late treatment provision. In Brazil, approximately 85% of the 442 infections are caused by P. vivax. P. falciparum is only transmitted in specific regions, including in 443 the one evaluated in this work ("Alto do Juruá" valley, Acre), where it is responsible for 46% of the 444 total infections in Brazil [13, 14] . Interestingly, despite Brazil being a low transmission area for 445 21 malaria with effective control strategies and early treatment provision, we observed adverse events 446 in newborns similar to those reported in areas of high endemicity.
447
Surprisingly, the prevalence of microcephaly (HC < -2 SD) observed by us is far higher than what 448 has been previously reported by the Brazilian Ministry of Health [12] . Two independent studies 449 have recently evaluated retrospectively babies born in two different Brazilian regions, and also 450 reported a higher prevalence of microcephaly in babies born before the Zika outbreak [38, 39] . In 451 one, 16,208 infants born between 2012 and 2015 in the Paraiba State (Brazil) were evaluated, and 452 4.2 to 8.2% of microcephaly prevalence was reported, depending on the classification criteria [38] . 453
In the other, 8,275 babies born between 2011 and 2015 in the southeastern and mid-western 454
Brazilian region were evaluated, and an overall prevalence of microcephaly of 5.6% was identified 455 Our work has some potential limitations. First, the babies' HC was only assessed at birth, since it 461 was not possible to perform the morphometric measures through ultrasonography during pregnancy 462 in the public health system, as well as the possibility of acquiring newborn head imaging. Second, 463 reduction of HC has different etiologies, namely, genetic causes and action of infectious agents. 464
While we have discarded misleading factors, such as TORCH infections, Syphilis, HIV, Dengue, 465
Chikungunya and Zika virus, as well as smoking, alcoholism and drug use, studies to detect genetic 466 abnormalities in those patients were not performed. Third, although in both the PCS and the RCS 467 infection status: malaria-and non-infected (NI) mothers (p = 0.008) (a), and NI, Pv, Mixed and Pf-743 infected mothers after excluding LBW and preterm babies (NI vs Pf p = 0.015) (b). The differences 744 in the frequency distributions between each group were examined with Mann-Whitney rank sum 745 tests. c Forest plot of the Odds Ratio of small head or microcephaly in babies born from women 746 infected during pregnancy compared to babies from non-infected women, according to Plasmodium 747 species. Mixed infection -P. vivax-and P. falciparum-infection occurring at the same time and/or 748 at different times during pregnancy. n/N -number of events by total number of individuals in each 749 group; CI -confidence interval; HC -head circumference; SD -standard deviation; p-Values were 750 estimated through multivariate logistic regression methods. 751 Table 1 . Infection characteristics in P. falciparum-infected pregnant women. 
